phdassistance

  • Have any questions?

CRISPR Gene Editing Dissertation Topics I phdassistance.com

Info: CRISPR Gene Editing Dissertation Topics I phdassistance.com

Published: 26th March in CRISPR Gene Editing Dissertation Topics I phdassistance.com

Share this:

Facebook
Twitter
Whatsapp
Linkedin

Related Services

Our academic writing and marking services can help you

Introduction

Scientists have developed CRISPR-based gene editing methods which enable them to make precise modifications to human microbiome systems that regulate metabolic processes, immune system functions and disease progression. Scientists can use the method to conduct precise alterations of microbial populations, which enables the development of new treatment techniques that fight antibiotic resistance and cancer through engineered probiotics and antimicrobial peptide production. Microbiome instability and horizontal gene transfer, together with undefined ethical and regulatory standards, make it difficult to implement these technologies, which leads to restricted clinical use. Scientists must create integrated methods that combine ecological assessment with systems biology and governance systems to develop safe and effective CRISPR gene editing microbiome therapeutic applications.

CRISPR

CRISPR Gene Editing Dissertation Topics I phdassistance.com

Proposed PhD Topic 1: Precision Phage- and Nanoparticle-Based CRISPR Delivery Systems for Selective Editing of Antimicrobial Resistance Genes in Complex Microbiome Environments

Background Context:

The current antimicrobial resistance crisis needs the development of targeted CRISPR for disease treatment. The review by Amen et al. (2025) published in Probiotics and Antimicrobial Proteins shows that CRISPR-based gene editing can accurately target resistance genes, although its use in medicine is restricted because of ineffective delivery methods. The current delivery methods treat all microorganisms the same way, which leads to harmful pathogens receiving equivalent treatment as helpful microbiota.

PhD-Level Verification:

No existing doctoral research has developed an integrated regulatory model that explains the process through which environmental hypoxia gets detected and its resulting rRNA modification patterns.

Research Questions:
  • How do researchers seek to develop bacteriophage-based delivery systems that deliver CRISPR Cas9 technology to specific genetic targets?
  • How does the study investigate nanoparticles to improve both delivery accuracy and delivery system durability?
  • how does Researchers find methods that decrease off-target effects during microbiome editing procedures?
    • PhD-Level Contributions:
  • CRISPR delivery platforms require the development of delivery systems that deliver CRISPR to specific target areas
  • Antimicrobial treatments now have better accuracy because researchers have developed advanced antimicrobial treatment methods
  • The beneficial microbiota that exists in the environment needs protection from various threats
  • The translational microbiome engineering field receives new knowledge because researchers have studied microbial systems.
    • Suggested Readings:

    Amen, R. A., Hassan, Y. M., Essmat, R. A., Ahmed, R. H., Azab, M. M., Shehata, N. R., Elgazzar, M. M., & El-Sayed, W. M. (2025). Harnessing the microbiome: CRISPR-based gene editing and antimicrobial peptides in combating antibiotic resistance and cancer. Probiotics and Antimicrobial Proteins, 17, 1938–1968. https://doi.org/10.1007/s12602-025-10573-8

    Proposed PhD Topic 2: CRISPR-Guided Engineering of Microbial Hosts for Enhanced Antimicrobial Peptides with Improved Stability, Bioavailability, and Broad-Spectrum Activity
    Background Context:

    According to Amen et al. (2025) in Probiotics and Antimicrobial Proteins, antimicrobial peptides (AMPs) demonstrate a strong ability to fight infections and cancer, which makes them potential replacements for traditional antibiotic treatments. The clinical use of these substances is restricted because they face multiple challenges, which include their poor structural stability, their low bioavailability in human body conditions and their diminished effectiveness against resistant bacteria. The existing obstacles prevent the successful development of these products for medical applications. The use of CRISPR-based Gene editing technology provides scientists with an efficient method to develop microbial systems that produce antimicrobial peptides at higher levels and achieve superior structural and functional characteristics for medical use.

    PhD-Level Verification:

    Currently available academic research does not exist that combines CRISPR-based microbial engineering with advanced AMP optimisation techniques to achieve stable delivery systems that enhance therapeutic performance.

    Research Questions:

    How can CRISPR be used for improving microbial production of antimicrobial peptides?

    Which CRISPR in genetic disease treatment lead to better antimicrobial peptide stability and protection against enzymatic breakdown?

    Can engineered antimicrobial peptides enhance treatment effectiveness against multidrug-resistant pathogens?

    PhD-Level Contributions:
  • Development of CRISPR-enhanced AMP production systems
  • Improved peptide stability, functionality, and therapeutic efficacy
  • Expansion of AMP applications in antimicrobial and anticancer therapies
  • Integration of synthetic biology approaches with clinical therapeutic development
    • Suggested Readings:

    Amen, R. A., Hassan, Y. M., Essmat, R. A., Ahmed, R. H., Azab, M. M., Shehata, N. R., Elgazzar, M. M., & El-Sayed, W. M. (2025). Harnessing the microbiome: CRISPR-based gene editing and antimicrobial peptides in combating antibiotic resistance and cancer. Probiotics and Antimicrobial Proteins, 17, 1938–1968. https://doi.org/10.1007/s12602-025-10573-8

    Proposed Dissertation topic 3: CRISPR-Engineered Probiotic Platforms for Targeted Delivery of Anticancer Peptides within Tumour Microenvironments
    Background Context:

    The study by Amen et al. (2025) in Probiotics and Antimicrobial Proteins shows that engineered probiotics now serve as advanced delivery systems which can effectively transport therapeutic molecules. The systems provide targeted delivery which decreases their harmful effects on the entire body. The system requires three main components to function properly which include controlled gene expression and tumor-specific activation and safe effective host immune system interactions. The microbiome-based cancer therapies need these challenges to be solved before they can make progress.

    PhD Level Verification:

    No existing doctoral-level framework comprehensively integrates CRISPR-based probiotic engineering with tumour-targeted delivery mechanisms and immune system modulation strategies.

    Research Questions:
  • How can CRISPR-engineered probiotics be optimised for efficient delivery of anticancer peptides?
  • What biological mechanisms enable selective activation within tumour microenvironments?
  • How do engineered probiotics interact with and influence host immune responses?
  • Can these advanced systems improve therapeutic outcomes compared to conventional cancer treatments?
    • PhD-Level Contributions:
  • Development of advanced microbiome-based cancer therapy platforms.
  • Integration of CRISPR editing with targeted delivery technologies.
  • Development of personalised oncology methods through precision oncology research.
  • The research achieved two objectives, which included decreasing systemic toxicity and increasing treatment precision.
    • Suggested Readings:

    Amen, R. A., Hassan, Y. M., Essmat, R. A., Ahmed, R. H., Azab, M. M., Shehata, N. R., Elgazzar, M. M., & El-Sayed, W. M. (2025). Harnessing the microbiome: CRISPR-based gene editing and antimicrobial peptides in combating antibiotic resistance and cancer. Probiotics and Antimicrobial Proteins, 17, 1938–1968. https://doi.org/10.1007/s12602-025-10573-8

    Proposed Dissertation Topic 4: Integrative Multi-Omics and CRISPR Functional Genomics Framework for Understanding Microbiome-Driven Mechanisms in Disease Progression

    Background Context:

    The authors of Amen et al. (2025) demonstrated advanced sequencing technologies together with metagenomics, metatranscriptomics and metabolomics to provide complete details about microbiome composition and activity in their study published in Probiotics and Antimicrobial Proteins. The methods fail to demonstrate how microbial functions lead to particular disease results. The CRISPR gene system functions as a highly effective instrument for testing the purposes of bacterial genes and their associated genetic pathways. The scientific field lacks sufficient research on how to combine multi-omics datasets with CRISPR experimental work for functional analysis research.

    PhD-Level Verification:

    No doctoral research has fully developed an integrated framework that combines multi-omics approaches with CRISPR-based validation to investigate microbiome-driven mechanisms in disease progression.

    Research Questions:
  • How can researchers achieve successful integration of multi-omics datasets with CRISPR-based functional experiments?
  • Which microbial genes and pathways serve as main contributors to disease development and progression?
  • Can CRISPR establish the causal links between microbiome composition and health effects on host organisms?
  • This integrated method will advance precision medicine by enabling development of customized medical treatments.
    • Contributions at the PhD-Level:
  • The team built a complete multi-omics system, which they combined with a CRISPR system to build their new research platform.
  • The team discovered new therapeutic targets, which they based on microbiome research.
  • The research provided new insights into how hosts interact with their microbiome.
  • The work supports both data-driven medicine and precision medicine methods.
    • Suggested Readings:

    • Amen, R. A., Hassan, Y. M., Essmat, R. A., Ahmed, R. H., Azab, M. M., Shehata, N. R., Elgazzar, M. M., & El-Sayed, W. M. (2025). Harnessing the microbiome: CRISPR-based gene editing and antimicrobial peptides in combating antibiotic resistance and cancer. Probiotics and Antimicrobial Proteins, 17, 1938–1968. https://doi.org/10.1007/s12602-025-10573-8

    Proposed Dissertation Topic 5: Ethical, Regulatory, and Ecological Frameworks for the Clinical Translation of CRISPR-Based Microbiome Engineering and Therapeutics

    Background Context:

    The review by Amen et al. (2025) in Probiotics and Antimicrobial Proteins shows that CRISPR-based microbiome therapies face major ethical, regulatory and ecological challenges because of the fast technological progress. The problems include two main areas that concern scientists about microbiome stability over time and ecological impacts, and which lack complete regulatory systems needed to manage these advanced technologies. The safe and responsible use of microbiome-based treatments in clinical settings depends on resolving these matters.

    PhD-Level Verification:

    Amen et al. (2025) discovered essential deficiencies that stop scientists from transferring microbiome treatments to actual Applications of CRISPR in medicine. The existing research systems for doctoral students have not established a comprehensive system to study ethical matters together with regulatory requirements and ecological impacts.

    Research Questions:
  • How can researchers establish methods to predict and track CRISPR-based microbiome treatments across extended time periods?
  • Which ethical and regulatory structures must be established to ensure secure implementation of clinical research?
  • Which ecological hazards emerge from engineered microbiomes through their off-target effects and gene transfer potential?
    • PhD-Level Contributions:
  • The integrated ethical regulatory ecological framework establishes guidelines for microbiome therapeutic development.
  • The systems biology model demonstrates how CRISPR interacts with the microbiome.
  • The ecological risk assessment model evaluates potential environmental impacts of engineered microbiomes.
  • The guideline provides a framework for implementing clinical research through its translational guidelines.
    • Suggested Readings:

    Amen, R. A., Hassan, Y. M., Essmat, R. A., Ahmed, R. H., Azab, M. M., Shehata, N. R., Elgazzar, M. M., & El-Sayed, W. M. (2025). Harnessing the microbiome: CRISPR-based gene editing and antimicrobial peptides in combating antibiotic resistance and cancer. Probiotics and Antimicrobial Proteins, 17, 1938–1968. https://doi.org/10.1007/s12602-025-10573-8

    Need assistance finalising your dissertation topic? Selecting a strong, researchable topic can be challenging — but you don’t have to do it alone.
    Our research consultants can help refine your ideas, identify literature gaps, and guide you toward a topic that aligns with current academic trends and your programme requirements.
    Contact us to begin one-on-one topic development and refinement with PhdAssistance.com Research Lab.

    Share this:

    Facebook
    Twitter
    Whatsapp
    Linkedin

    Cite this work

    Study Resources

    Free resources to assist you with your university studies!

    Research Questions